By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted July 27, 2022APYX MEDICAL CORPORATION RELEASES ENVIRONMENTAL, SOCIAL AND GOVERNANCE DATA IN NEW TEAR SHEET READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted July 18, 2022RENUVION CLEARED BY FDA FOR NECK LAXITY PROCEDURES OFFERING PATIENTS A MINIMALLY INVASIVE OPTION TO ELIMINATE SAGGING NECK READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted July 18, 2022APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO IMPROVE APPEARANCE OF LAX (LOOSE) SKIN READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted July 8, 2022APYX MEDICAL CORPORATION ANNOUNCES RESULTS OF THE U.S. IDE CLINICAL STUDY EVALUATING THE USE OF RENUVION TO IMPROVE THE APPEARANCE OF LAX SKIN IN THE NECK AND SUBMENTAL REGION READ MORE
